CIK: 0001381843 · Show all filings
Period: Q2 2021 (← Previous) (Next →)
Filing Date: Aug 10, 2021
Total Value ($000): $105,528 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| IRWD | IRONWOOD PHARMACEUTICALS INC | 1,520,000 | $19,562 | 18.5% | $10.81 | +5.9% | COM CL A | 46333X108 |
| SUPN | SUPERNUS PHARMACEUTICALS INC | 530,000 | $16,319 | 15.5% | $22.36 | +37.1% | COM | 868459108 |
| VRTX | VERTEX PHARMACEUTICALS INC | 52,000 | $10,485 | 9.9% | $216.22 | -3.3% | COM | 92532F100 |
| ARAY | ACCURAY INC | 2,300,000 | $10,396 | 9.9% | $4.02 | +16.4% | COM | 004397105 |
| MCK | MCKESSON CORP | 52,000 | $9,944 | 9.4% | $166.27 | +13.1% | COM | 58155Q103 |
| BMY | BRISTOL-MYERS SQUIBB CO | 147,000 | $9,823 | 9.3% | $50.54 | +6.6% | COM | 110122108 |
| CI | CIGNA CORP NEW | 41,000 | $9,720 | 9.2% | $197.83 | +16.1% | COM | 125523100 |
| CAH | CARDINAL HEALTH INC | 170,000 | $9,705 | 9.2% | $48.62 | +7.4% | COM | 14149Y108 |
| ABBV | ABBVIE INC | 85,000 | $9,574 | 9.1% | $81.92 | +15.7% | COM | 00287Y109 |